MENU
+Compare
SPHRY
Stock ticker: OTC
AS OF
Jul 3 closing price
Price
$0.64
Change
+$0.05 (+8.47%)
Capitalization
25.05M

SPHRY Starpharma Holdings Ltd. Forecast, Technical & Fundamental Analysis

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications... Show more

SPHRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for SPHRY with price predictions
Jul 03, 2025

SPHRY in downward trend: price may drop because broke its higher Bollinger Band on July 03, 2025

SPHRY broke above its upper Bollinger Band on July 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 35 similar instances where the stock broke above the upper band. In of the 35 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where SPHRY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 03, 2025. You may want to consider a long position or call options on SPHRY as a result. In of 84 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SPHRY just turned positive on July 03, 2025. Looking at past instances where SPHRY's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

SPHRY moved above its 50-day moving average on July 01, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SPHRY crossed bullishly above the 50-day moving average on July 03, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 107 cases where SPHRY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.753) is normal, around the industry mean (16.666). P/E Ratio (0.000) is within average values for comparable stocks, (58.763). SPHRY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.315). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (13.495) is also within normal values, averaging (269.614).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SPHRY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SPHRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
SPHRY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4-6 Southampton Crescent
Phone
+61 385322700
Employees
32
Web
https://www.starpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRYGF0.17N/A
+2.68%
DRYDEN GOLD CORP.
OMVKY13.930.12
+0.87%
OMV AG
EQTRF0.08N/A
+0.65%
Altamira Gold Corp
JTEKY24.00N/A
N/A
JTEKT Corp.
VTEPF0.89N/A
N/A
VIDENDUM PLC

SPHRY and Stocks

Correlation & Price change

A.I.dvisor tells us that SPHRY and VACBF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SPHRY and VACBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SPHRY
1D Price
Change %
SPHRY100%
+8.88%
VACBF - SPHRY
29%
Poorly correlated
N/A
TTNP - SPHRY
27%
Poorly correlated
+1.15%
SPHRF - SPHRY
25%
Poorly correlated
N/A
ASPHF - SPHRY
22%
Poorly correlated
N/A
INM - SPHRY
21%
Poorly correlated
-4.59%
More